Richard Vosser

Stock Analyst at JP Morgan

(1.48)

# 3,152

Out of 4,825 analysts

10

Total ratings

57.14%

Success rate

-1.81%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Richard Vosser

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MOLN Molecular Partners AG	Maintains: Neutral	$6.6 → $4.5	$3.75	+20.08%	1	Dec 5, 2023
	NVO Novo Nordisk	Upgrades: Overweight	n/a	$65.60	-	7	Jun 7, 2022
	SNY Sanofi	Upgrades: Overweight	n/a	$54.10	-	2	Jan 6, 2020

Molecular Partners AG

Dec 5, 2023

Maintains: Neutral

Price Target: $6.6 → $4.5

Current: $3.75

Upside: +20.08%

Novo Nordisk

Jun 7, 2022

Upgrades: Overweight

Price Target: n/a

Current: $65.60

Upside: -

Sanofi

Jan 6, 2020

Upgrades: Overweight

Price Target: n/a

Current: $54.10

Upside: -